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Abstract 
Mycoplasma pneumoniae (M. pneumoniae) frequently causes community-acquired respiratory tract infection and 
often presents as atypical pneumonia. Following airborne infection and a long incubation period, affected patients 
mostly suffer from mild or even asymptomatic and self-limiting disease. In particular in school-aged children, M. pneu-
moniae is associated with a wide range of extrapulmonary manifestations including central nervous system (CNS) 
disease. In contrast to children, severe CNS manifestations are rarely observed in adults. We report a case of a 37 year-
old previously healthy immunocompetent adult with fulminant M. pneumoniae-induced progressive encephalomyeli-
tis who was initially able to walk to the emergency department. A few hours later, she required controlled mechanical 
ventilation for ascending transverse spinal cord syndrome, including complete lower extremity paraplegia. Severe 
M. pneumoniae-induced encephalomyelitis was postulated, and antimicrobial, anti-inflammatory and immunosup-
pressive therapy was applied on the intensive care unit. Despite early and targeted therapy using four different 
immunosuppressive strategies, clinical success was limited. In our patient, locked-in syndrome developed followed 
by persistent minimally conscious state. The neurological status was unchanged until day 230 of follow-up. Our case 
underlines that severe M. pneumoniae- related encephalomyelitis must not only be considered in children, but also in 
adults. Moreover, it can be fulminant and fatal in adults. Our case enhances the debate for an optimal antimicrobial 
agent with activity beyond the blood–brain barrier. Furthermore, it may underline the difficulty in clinical decision 
making regarding early antimicrobial treatment in M. pneumoniae disease, which is commonly self-limited.
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Background
Mycoplasma pneumoniae (M. pneumoniae) is a small 
bacterium that lacks a rigid cellular wall. It is consid-
ered highly contagious and airborne infection may result 
in atypical pneumonia following a longer incubation 
period (Waites and Talkington 2004; Waites and Atkin-
son 2009). Most often, M. pneumoniae-induced atypical 
pneumonia can be treated in an outpatient setting and 
the clinical course is commonly mild and self-limiting 
or even asymptomatic (Spuesens 2014). Importantly, 
in particular in school-aged children (Christie et  al. 
2007), M. pneumoniae is associated with a wide range 
of extrapulmonary manifestations including mucocu-
taneous and central nervous system (CNS) disease. In 
few cases severe encephalomyelitis develops (Waites 
and Talkington 2004; Christie et  al. 2007; Daxboeck 
2006; Granerod et  al. 2010; Tsiodras et  al. 2005; Atkin-
son and Waites 2014). Here we report a rare case of M. 
pneumoniae-infection with resulting locked-in syndrome 
progressing to minimally conscious state in a previously 
healthy immunocompetent adult.
Case history
A 37-year-old Caucasian woman presented to the emer-
gency department with a 10-day history of productive 
cough, low-grade fever (38.5  °C), generalized myalgia, 
and lower extremity weakness. Several days before 
onset of symptoms, her 2-year old daughter experienced 
mild dyspnea and fever. At clinical examination, basal 
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lung field crepitation was noted. The WBC count was 
13 g/L and C-reactive protein level 38 mg/L. Neurologi-
cal examination revealed homonymous left hemianop-
sia, reduced sensitivity to tactile/painful stimuli (below 
Th6-level), lower extremity paraparesis (global strength 
M2–M3) with areflexia, and urinary retention. Strength 
of upper extremities was tested normal. Except for bilat-
eral interstitial pulmonary infiltrates, whole body CT-
scans returned unremarkable. A cerebral CT angiogram 
and a subsequent MR-angiogram did not reveal signs of 
vasculopathy.
Within 2  h, complete lower extremity paraplegia and 
ascending transverse spinal cord syndrome (Th2-level) 
developed and required invasive controlled mechanical 
ventilation. Cerebral and spinal MRI showed extensive 
myelitis. Differential diagnoses of fulminant encepha-
lomyelitis included infectious, parainfectious, auto-
immune/inflammatory, paraneoplastic, and acquired 
CNS demyelinating disease. Lumbar puncture revealed 
polynucleated pleocytosis (95  M/L WBC, 67  % polynu-
cleated; protein 3.34  g/L, lactate 6.90  mmol/L, glucose 
2.67  mmol/L) with positively tested polyclonal bands. 
In addition to clarithromycin, the empirical antimicro-
bial treatment consisted of ceftriaxone, ampicillin, and 
acyclovir. CSF-analyses for HSV-I/-II, VZV, CMV, EBV, 
enteroviruses, tuberculosis, bacterial growth, and sero-
logical testing for HIV, syphilis, tick-borne encephali-
tis, hepatitis, and autoimmune disease (anti-nuclear-, 
anti-neutrophil cytoplasmatic-, anti-cardiolipin-, and 
neuromyelitis optica antibodies) were negative. How-
ever, nasopharyngeal swab (PCR), serum antibodies, and 
CSF-tests returned positive for M. pneumoniae [serum-
IgG 159 U/L (normal range <20 U/L); serum-IgM 46 U/L 
(<13 U/L)], with a positive serum to CSF IgM-ratio [3.8 
(<1.3)]. The diagnosis of rapidly progressive M. pneumo-
niae-induced encephalomyelitis was postulated (Tsiodras 
et  al. 2005). Few hours following initial admission, the 
antimicrobial treatment was streamlined to moxifloxacin 
(400  mg daily), tetracycline, and pulse methylpredniso-
lone (1 g/day) was added thereafter for 7 days (Carpenter 
2002).
On day 2, flaccid quadriplegia with complete areflexia 
and sensory loss (C3-level) developed. Communication 
was possible by means of head movement only. Finally, 
cranial nerve function diminished with only vertical 
eye movement preserved and locked-in syndrome was 
diagnosed. Repeated MRI demonstrated a diffusion 
restriction accompanied by predominantly subcortical 
T2-hyperintensities (along splenium/corpus callosum, 
inferior parietal lobe, brainstem) extending into the cer-
vical spine (Fig.  1). Supported only by anecdotal data 
(Cotter et al. 1983), plasmapheresis for severe para-infec-
tious encephalomyelitis was performed (five sessions QD, 
followed by five sessions QOD). With decreasing alert-
ness, cyclophosphamide (1  g/dose, days 10 and 24) and 
infliximab (375 mg/m2, day 40) was administered without 
clinical effect. A corpus callosum biopsy revealed exten-
sive demyelination, though PCR for M. pneumoniae was 
negative. A tracheostomy for long-term mechanical ven-
tilation was performed on day 10 and moxifloxacin was 
continued for a total of 21  days. Prednisolone was pro-
gressively tapered and in the further course and the daily 
dosage at discharge was 25 mg.
At day 58, eye movements lapsed and MRIs showed 
extensive necrotizing encephalitis with hemorrhagic 
transformation and blood–brain barrier disruption 
within cervicospinal lesions (Fig.  1). Resting-state func-
tional MRI to assess default mode network (DMN) con-
nectivity was performed (Fig. 2) (Whitfield-Gabrieli and 
Nieto-Castanon 2012). Connectivity was preserved in the 
posterior DMN i.e. between the precuneus (a core struc-
ture regarding connectivity loss in comatose patients) 
and inferior parietal lobe, and a reduction between pos-
terior DMN and anterior cingulate cortex. Thus, clinical 
and imaging findings indicated progression of locked-in 
syndrome to minimally conscious state (Demertzi et  al. 
2015). Finally, following extensive communication with 
next-of-kin, the patient was discharged to a nursing home 
on controlled mechanical ventilation. Follow-up until day 
230 confirmed a persistent neurological status.
Discussion
The case presented here demonstrates fulminant progres-
sion of transverse encephalomyelitis. Main differential 
diagnoses include systemic autoimmune disease, parane-
oplastic and acquired CNS demyelinating disease (such 
as neuromyelitis optica or multiple sclerosis), as well as 
infectious, postinfectious, or paravaccinal disorders, and 
acute demyelinating encephalomyelitis (Frohman and 
Wingerchuk 2010).
Today, underlying pathomechanisms for M. pneumo-
niae-induced encephalomyelitis remain incompletely 
understood. Currently debated major pathomechanisms 
include direct bacteremia-induced or other invasive (i.e. 
per continuitatem) CNS-injury, effects related to bac-
terial neurotoxins, as well as immune-complex medi-
ated or molecular mimicry-induced (auto-)immune 
responses (Daxboeck 2006; Tsiodras et  al. 2005; Spues-
ens et al. 2014). Although the consequences are currently 
unclear, e.g. polyclonal B cell activation in combination 
with production of distinct auto-antibodies were previ-
ously described in M. pneumoniae disease (Biberfeld 
1971). Nevertheless, evidence on optimal treatment for 
severe M. pneumoniae-induced encephalomyelitis is 
limited. This clinical dilemma seems further aggravated 
by the fact that diagnosis of M. pneumoniae induced 
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meningo-encephalitis by serological tests seems chal-
lenging due to lack of assays with high sensitivity and 
specificity. Nevertheless, before the background of the 
assumed immunopathogenesis of the disease, most 
experts recommend immunosuppressive therapy (Dax-
boeck 2006; Tsiodras et al. 2005).
In the case presented here, we applied early anti-micro-
bial therapy with postulated sufficient CSF-blood ratio 
and four different immunomodulating strategies right 
after onset of acute neurological symptoms.
Importantly, current available data do not allow 
concluding on optimal choice, timing and dosage of 
immunomodulating strategies in this clinical setting and 
the role of additional infection-induced acquired immu-
nodeficiency (Hotchkiss et al. 2013; Schefold et al. 2008) 
remains enigmatic. However, despite advanced immuno-
suppressive treatment, it seems worth to note that severe 
secondary infection was not noted in our patient. Unfor-
tunately, we observed that despite early anti-microbial, 
anti-inflammatory and immunosuppressive therapy, clin-
ical success was limited in our patient.
The clinical course of our patient underlines that M. 
pneumoniae-induced encephalomyelitis is a severe con-
dition that must not only be considered in younger 
Fig. 1 Baseline cerebral CT scan (upper left side) and cerebral and spinal MRI at days 1, 2, and 58, respectively
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children but also in adults. In addition, this case under-
lines the difficulty in clinical decision making regarding 
early antimicrobial treatment in M. pneumoniae disease, 
which is commonly self-limited.
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